Skip to main content
. 2021 Apr 30;16(4):e0251010. doi: 10.1371/journal.pone.0251010

Table 4. Independent risk factors for GNB in CRBSI in neutropenic oncological and hematological patients.

Adjusted odds ratio (95% CI) p-value
Older age 1.016 (1.001–1.033) 0.043
Longer duration of in-situ catheter 1.007 (1.004–1.011) <0.001
Prior antibiotic therapy with penicilins± 2.716 (1.366–5.403) 0.004
Current antibiotic therapy with glycopeptides 1.931 (1.001–3.306) 0.041

±Consisting of piperacillin-tazobactam, amoxicillin, ampicillin, amoxicillin-clavulanate and cloxacillin.